Background: Chronic Kidney Disease (CKD) can be defined as an estimated glomerular Filtration Rate (eGFR) of less than ml/min/1.73 m2 for a minimum period of three months. CKD is commonly associated with various hematological abnormalities specially anemia. Aim: The present study was planned to assess the hematological variations in CKD patients as compared to healthy subjects. Method: Fifty patients diagnosed for CKD were enrolled for the study. Fifty age and sex matched healthy subjects constituted the control group. Result: On comparison of the hematological profile, it was observed that all enrolled CKD patients were anemic with a hemoglobin (Hb) less than 13g/dL in males and less than 12 g/dL in females. The mean Hb levels were as low as 7.50 + 1.55 g/dL (P< 0.0001). Correspondingly, total RBC count of CKD patients was also low. It was also observed that platelet count was slightly low among CKD patients. However the mean level was comparable with control group (P=NS). On further analysis, it was observed that among fifty CKD patients, 46% (n=23) suffered from severe anemia i.e. Hb < 7 gm/dL whereas 48% had moderate anemia i.e. Hb between 7-9.9 gm/dL. However, only 12 % (n=6) CKD patients suffered from thrombocytopenia i.e. platelets count < 1.50 lack/ cmm. Conclusion: Hematological abnormalities may lead to several associated morbidities and may pose a challenge for maintenance of overall health status for CKD patient. Hence, there is need to monitor hematological profile of CKD patients specially those on dialysis so that any abnormality can be detected and managed accordingly. Keywords: Chronic kidney disease, Anemia, Hematological changes, Potassium, Platelets.
Introduction: Cirrhosis is an advanced stage of liver fibrosis that is accompanied by distortion of the hepatic vasculature. It is the histological development of regenerative nodules surrounded by fibrous bands in response to chronic liver injury. Objectives: The study was intended to assess serum Triiodothyronine (T3), Thyroxine (T4) levels and Thyroid Stimulating Hormone (TSH) on the basis of Child Pugh Score in patients with Liver Cirrhosis. Methodology: 100 clinically diagnosed cases of Liver Cirrhosis patients were enrolled for the study. Estimation of Thyroid Hormones were performed. Statistical evaluation was done for analysis of the results. Result: The study documented a significant decrease in T3 levels (P= <0.0001), a non-significant increase in T4 levels (P=0.997) and a slightly significant increase in TSH levels (P=0.034) on the basis of CP Score. Conclusion: The patients with liver cirrhosis have significantly decreased levels of T3 with increased CP Score. The routine liver enzymes like AST, ALT and ALP may be unable to predict the risk of development of liver cirrhosis specially in the early stages. Therefore, screening of serum T3 levels is strongly recommended in patients with early-stage liver diseases like ALD, NAFLD, NASH and CLD.
AIM: The study was planned to evaluate the association of C - reactive protein with Serum Uric Acid and Bicarbonate Level in COPD. MATERIAL AND METHODS: In the present study total 100 (n=100) patients diagnosed for COPD, were enrolled for the study. Patients with neoplastic pathologies, pneumonia and Liver or renal diseases, pregnant and lactating females were excluded from the study. RESULT: The mean level of Serum Bicarbonate, C-reactive protein and uric acid were signicantly higher in COPD patients. A signicant association was observed (p ≤ 0.0001). CONCLUSION: In the present study higher bicarbonate levels that could be the individual biomarker which can assess the respiratory acidosis and CRP and Uric Acid levels judges the severity the disease.
Type II diabetes mellitus (DM) is the most common endocrine disorder and a leading cause of morbidity and mortality across the world. Long-standing diabetes and a poor glycemic control are the major factors which contribute to the development of various microvascular complications of diabetes. Microvascular changes in kidneys lead to microalbuminuria, which may further lead to end-stage renal disease (ESRD) if left untreated. Elevated serum uric acid level has been recognized as a marker of endothelial dysfunction which contributes to the development of microvascular changes in various organs. The main objective of the present study was to assess the association of serum uric acid and urine microalbumin levels with glycosylated hemoglobin (HbA1c) in type II DM patients. One hundred diagnosed cases of type II DM were enrolled for the study. Blood samples were collected and estimated for fasting blood sugar, serum uric acid, and HbA1c. Also, 24-hour urine samples were collected and analyzed for microalbumin. A positive association (r = 0.203) was observed between HbA1c and serum uric acid. The study also suggested a positive association between glycemic control and microalbuminuria (r = 0.237) in diabetic patients. A strong positive association was also observed between uric acid and urine microalbumin levels (r = 0.338). Findings of the study, therefore, recommend that development of microvascular complications in type II DM patients can be averted by adopting dietary control and healthy lifestyle changes. Strict glycemic control and lowering of serum uric acid levels can be helpful in minimizing the risk of developing nephropathy and its progression toward ESRD. How to cite this article Fiza B, Yogi JP, Choudhary J, Semar A, Sinha M. Association of Hyperuricemia and Urinary Albumin Excretion with Glycosylated Hemoglobin in Patients with Type II Diabetes Mellitus. J Mahatma Gandhi Univ Med Sci Tech 2017;2(1):1-6.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.